BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy

• Andrea Icks,
• Dan Ziegler,
• Alexander Strom,
• Gidon J Bönhof,
• Michael Roden,
• Christian Herder,
• Klaus Strassburger,
• Claudia Reule,
• Oliver Kuss,
• Gundega Sipola,
• Birgit Knebel,
• Jan-Christoph Wollmann,
• Hadi Al-Hasani

Affiliations

Andrea Icks

Institute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Dan Ziegler

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Alexander Strom

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Gidon J Bönhof

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Michael Roden

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Christian Herder

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Klaus Strassburger

German Center for Diabetes Research, Partner Düsseldorf, Munich-Neuherberg, Germany

Claudia Reule

Wörwag Pharma GmbH und Co KG, Böblingen, Germany

Oliver Kuss

Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Gundega Sipola

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany

Birgit Knebel

German Center for Diabetes Research, Partner Düsseldorf, Munich-Neuherberg, Germany

Jan-Christoph Wollmann

Wörwag Pharma GmbH und Co KG, Böblingen, Germany

Hadi Al-Hasani

German Center for Diabetes Research, Partner Düsseldorf, Munich-Neuherberg, Germany